Ractigen Therapeutics

Founded 2017 · $78.0M raised

Employees
51–200
Founded
2017
Total Funding
$78.0M
Last Round
$31.0M Venture RoundJul 2026
Rounds
3

About

Ractigen Therapeutics is a clinical-stage pharmaceutical company specializing in developing pioneering therapies aimed at enhancing the expression of therapeutic genes within diseased cells. Founded in 2017 by trailblazers in RNA activation (RNAa) research, the company builds on a foundational discovery at the University of California, San Francisco (UCSF) to create duplex saRNA therapeutics that target diseases arising from inadequate gene expression. Its main headquarters is located in the bioBAY area of Suzhou, spanning 2200 square meters with certified BSL-2 biology laboratories, alongside an oligonucleotide manufacturing facility in Rudong, Jiangsu, and a business development office in Shanghai.

Summary

Ractigen Therapeutics is a Drug Discovery company, founded in 2017. It has raised $78.0M in total across 3 rounds, most recently a $31.0M Venture Round round in Jul 2026. Investors include SDIC Venture Capital and Huimei Capital.

Funding History

$31.0M

Sign up to see all 3 rounds

Series A through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ractigen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ractigen-therapeutics"><img src="https://indexed.vc/api/badge/company/ractigen-therapeutics" alt="Ractigen Therapeutics on Indexed.vc" width="260" height="76" /></a>